Clinical Trials

PADCEV plus KEYTRUDA is the first and only regimen to improve survival when used before and after standard of care (surgical cystectomy) in cisplatin-ineligible patients with muscle-invasive bladder cancer Results will be discussed with global health authorities for...

In order to treat multiple myeloma in adults, Sarclisa from Sanofi in combination with a regimen of lenalidomide, bortezomib, and dexamethasone (VRd) has been granted approval by the European Commission. It is well to be noted that Sarclisa has received...

The UK government will improve manufacturing and commercialisation as it seeks to maximise the value of the life sciences sector growth for the country's economy. In a new Life Sciences sector growth plan, the government established a six-point action plan...

In the past few years, there has been a positive movement toward using technology to change how patients are engaged and how they stay with a practice. A lot of different kinds of technology are changing the way clinical...

Scientists applied artificial intelligence (AI) to reanalyse a clinical trial for AI in Alzheimer Drug Development, identifying a group of patients who responded to medical treatment. The study shows that AI can help design future clinical trials to be...

Two Vaccines against the Nipah virus, a deadly bat-borne virus, are scheduled to begin human clinical trials in Bangladesh, while intriguing medication candidates have demonstrated the ability to treat and prevent infection. While Nipah case numbers remain low, climate change...

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the initiation of the EXPrESSIVE Phase 3 clinical trials, evaluating the safety and efficacy of MK-8527, an investigational once-monthly, oral nucleoside reverse transcriptase translocation...